tiprankstipranks
Renovaro Biosciences Inc. (RENB)
:RENB
US Market

Renovaro Biosciences (RENB) Income Statement

Compare
147 Followers

Renovaro Biosciences Income Statement

Last quarter (Q1 2024), Renovaro Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Renovaro Biosciences's net income was $-44.21M. See Renovaro Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -121.86K$ -113.50K$ -123.59K$ -391.42K$ -366.27K
Operating Expenses
$ 81.64M$ 19.60M$ 22.83M$ 23.40M$ 11.92M
Depreciation and Amortization
$ 121.86K$ 113.50K$ 123.59K$ 123.53K$ 366.27K
EBITDA
$ -79.52M$ -19.48M$ -22.70M$ -23.28M$ -11.51M
Operating Income
$ -81.64M$ -38.56M$ -116.08M$ -23.40M$ -11.92M
Other Income/Expenses
$ 989.12K$ -1.13M$ 2.65M$ -3.45M$ 507.41K
Pretax Income
$ -80.65M$ -39.68M$ -113.43M$ -26.85M$ -11.42M
Net Income
$ -80.65M$ -39.68M$ -113.43M$ -26.72M$ -11.42M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.84$ -0.71$ -2.16$ -0.57$ -0.25
Diluted EPS
$ -0.84$ -0.71$ -2.16$ -0.57$ -0.25
Weighted Average Shares Outstanding
96.25M 56.27M 52.53M 47.17M 46.33M
Weighted Average Shares Outstanding (Diluted)
96.25M 56.27M 52.53M 47.17M 46.33M
Currency in USD

Renovaro Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis